To determine if differences in tumor burden were a result of proliferating tumor cells, a proliferating cell nuclear antigen (PCNA) antibody was used on omental metastases, however, no significant difference in proliferating tumor cells colonizing MSLNWT and MSLNKO omental metastases was observed (Figure 6C,D). Here, PCNA is linked to neoplasm.